Open-Angle Glaucoma Market Size in the 7MM was found to be USD 3,316.71 million in 2017.
The total prevalent population of Glaucoma in the 7MM was 9,819,080 in 2017.
Rich Emerging Pipeline, Development of Advanced Antiglaucoma Medications, Patient-Friendly Dosage Regimes, Rise in Awareness, and Development of Treatment Methods to Tackle the Situation of Non-Adherence are the Open-Angle Glaucoma market drivers .
Some of the key players in Open-Angle Glaucoma Market include Peregrine Ophthalmic, Ocuphire Pharma, Envisia Therapeutics, Sylentis SA, Nicox Ophthalmics, Chong Kun Dang Pharmaceutical Corp, Santen Pharmaceutical, Sofia Labs, LLC, Sun Pharma Advanced Research, Allergan, Ocular Therapeutix , and others.
For more detailed information visit:
https://www.delveinsight.com/report-store/open-angle-glaucoma-market